Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
Express Scripts
Baxter
AstraZeneca

Last Updated: June 26, 2022

Investigational Drug Information for Lapaquistat


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Lapaquistat?

Lapaquistat is an investigational drug.

There have been 16 clinical trials for Lapaquistat. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2005.

The most common disease conditions in clinical trials are Hypercholesterolemia, Dyslipidemias, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Takeda and [disabled in preview].

Recent Clinical Trials for Lapaquistat
TitleSponsorPhase
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTakedaPhase 3
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTakedaPhase 3
Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTakedaPhase 2

See all Lapaquistat clinical trials

Clinical Trial Summary for Lapaquistat

Top disease conditions for Lapaquistat
Top clinical trial sponsors for Lapaquistat

See all Lapaquistat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
Express Scripts
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.